共 50 条
An economic model to assess the cost-benefit of BNCT
被引:4
|作者:
Kulvik, Martti
[1
,2
]
Hermans, Raine
[3
]
Linnosmaa, Ismo
[4
]
Shalowitz, Joel
[5
]
机构:
[1] Helsinki Univ Cent Hosp, Dept Neurol, Helsinki, Finland
[2] Res Inst Finnish Econ, Helsinki 00120, Finland
[3] Aalto Univ, Sch Econ, Helsinki, Finland
[4] Natl Inst Hlth & Welf, Helsinki, Finland
[5] Northwestern Univ, Kellogg Sch Management, Evanston, IL USA
关键词:
Technology;
Health care;
Costs;
BNCT;
WILLINGNESS-TO-PAY;
NEUTRON-CAPTURE THERAPY;
QUALITY-OF-LIFE;
TIME TRADE-OFF;
HEALTH-CARE;
GLIOBLASTOMA-MULTIFORME;
ADJUVANT TEMOZOLOMIDE;
MALIGNANT GLIOMA;
STANDARD GAMBLE;
BREAST-CANCER;
D O I:
10.1016/j.apradiso.2015.08.021
中图分类号:
O61 [无机化学];
学科分类号:
070301 ;
081704 ;
摘要:
We have constructed a formal model on cost-benefit of new technology in health care, and apply it on boron neutron capture therapy (BNCT). We assume that the patient health benefit from getting cured in acute treatment is always higher than the patient utility resulting from any long term treatment or death. This assumption makes it possible to evaluate the monetary cost impacts of a new technology and relate these measures to the patient health benefit. (C) 2015 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:3 / 9
页数:7
相关论文